Tumor testing and treatment patterns in veterans with metastatic castration-resistant prostate cancer.

Seminars in oncology(2023)

引用 0|浏览32
暂无评分
摘要
After the VA-PCF partnership, one-fifth of veterans with mCRPC received tumor testing, with most tests occurring in 2020-2021.
更多
查看译文
关键词
HRR mutation,Homologous recombination repair,Natural language processing,mCRPC
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要